Sempra logo SRE - Sempra

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 20
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $102.29 DETAILS
HIGH: $118.00
LOW: $84.00
MEDIAN: $102.00
CONSENSUS: $102.29
UPSIDE: 21.31%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 85% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Moderate
Trading 39.3% above fair value
Current Price $84.32
Bear Case $52.95 37.2% downside ($52.95 - $84.32) / $84.32 = -37.2% $3.78 × 14x P/E
Fair Value $60.52 28.2% downside ($60.52 - $84.32) / $84.32 = -28.2% $3.78 × 16x P/E
Bull Case $68.08 19.3% downside ($68.08 - $84.32) / $84.32 = -19.3% $3.78 × 18x P/E

Adjust Assumptions

16.0x
3.78$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 22.3x

Plain-Language Summary

Applying a 16x P/E to adjusted EPS of $3.78, the base-case value is $60.52 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (26 analysts) $102.29
Analyst Range $84.00 – $118.00
Divergence from AlphaVal 41%

Warnings

The company's reported profits differ from official accounting profits by 38%. Check what costs are being left out of the adjusted number.
The company pays out 95% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.
Wall Street's average price target is $102.29 (from 26 analysts). Our estimate is 41% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — terminal value assumptions dominate
  • EV/EBITDA misleading for regulated businesses where capex is mandated
  • Regulatory risk is a fat tail not visible in normal multiples